RE: The Investment Market for UK Diagnostic Companies14 Nov 2025 08:02
At the same time NHS trying to shift the focus to genomics lead care . Who know Genedrive may introduce multi panel tests on single machine .
The integration of genomics into everyday care is the dominant theme of the 2025 NGS Fit-for-the-Future 10 Year Health Plan (2025–2035): a pivotal strategy document that defines genomics as the central pillar of the future NHS.
The NHS plan marks the point where genomics becomes a core clinical function - driving pharmacogenomic decision support, preventing adverse drug events, accelerating clinical trial matching, enabling cell and gene therapy translation, and powering the next generation of mRNA cancer vaccines.
We are now watching genomics move into the 𝐜𝐨𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐬𝐲𝐬𝐭𝐞𝐦 𝐨𝐟 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞, and the implications are enormous. Hence Genomics can't be optional -- it must be core pathology training.
What the 2025 NHS 10 Year Health Plan tells us?
1. The scale Whole Genome Sequence for every baby within a decade signals a shift from niche genomics to mass market genomic screening
2. The funding (£650 m) and formal plan inclusion is a 𝐩𝐨𝐥𝐢𝐜𝐲 𝐜𝐨𝐦𝐦𝐢𝐭𝐦𝐞𝐧𝐭 (and not a research project)
3. The 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐨𝐟 𝐖𝐆𝐒 𝐛𝐞𝐲𝐨𝐧𝐝 𝐫𝐚𝐫𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 into major disease categories and population health means large test volume potential (hundreds of thousands or millions of genomes over years)
4. Panel testing will steadily give way to whole-genome sequencing in the years ahead as national strategies shift toward comprehensive genomics.
5. It is the expectation of NHS that half or more of healthcare events that occur in NHS (appointments and so on) will involve genomics by 2035
6. This will require massive upscaling of the amount of genomics that is going to be performed within the NHS
Sign In
Follow the stocks
